Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
A1F Glycan, 2-AA labelled is a specialized product commonly used in the research and development of novel drugs used for the treatment of various types of cancers and autoimmune diseases. This glycan is a modified form of A1F, which has been labelled with a 2-Aminobenzoic acid (2-AA) to enhance its ability to bind to specific receptors and increases bioavailability. Its unique properties make it an essential tool for scientists studying the mechanisms of certain diseases and developing targeted therapies. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A1F Glycan, 2-AB labelled
A1F Glycan, 2-AB labelled. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A1F N-Glycan
A1F N-Glycan, the versatile biomolecule employed by the biomedical industry, is the key player in the in-depth scrutiny and diagnosis of diverse disorders - think cancer, Alzheimer's, and rheumatoid arthritis. Its multifaceted involvement in cell signaling pathways has made it a go-to diagnostic marker in countless clinical settings. Furthermore, the therapeutic potential of A1F N-Glycan has not gone unexploited; it forms the crux of several drug formulations aimed at combating these afflictions. Group: Pharmaceutical. Alternative Names: Monosialo (2,6), fucosylated biantennary (A1F); A1F glycan; FA2G2S1 Glycan; Mono-sialylated, galactosylated, core-fucosylated, bi-antennary N-linked glycan; Mannotriose-(fucosyl-di-[N-acetylglucosamine]), mono-sialyl-bis(galactosyl-N-acetylglucosaminyl); NeuNAc(Gal-GlcNAc)2Man3(GlcNAc)2Fuc; β-D-Glucopyranose, O-(N-acetyl-α-neuraminosyl)-[2→3(or 2→6)]-O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-O-α-D-mannopyranosyl-[1→3(or 1→6)]-O-[O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-[1→6(or 1→3)]]-O-β-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→6)]-2-(acetylamino)-2-deoxy-. CAS No. 571188-30-2. Pack Sizes: 1mg;1g;10g. Produc
London
A1 Glycan, 2-AA labelled
A1 Glycan, 2-AA labelled, an indispensable instrument for exploring the intricacies of glycans linked to multifarious illnesses, encompassing cancer, Alzheimer's, and autoimmune disorders, is an asset to biomedical research. An integral part of comprehending the biological underpinnings and workings of these ailments, this product is vital in developing efficacious therapies. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A1 Glycan, 2-AB labelled
A1 Glycan, 2-AB labelled. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A1 N-Glycan
A1 N-Glycan is a versatile and Indispensable compound orchestrating numerous vital biological phenomena encompassing the domains of cell adhesion, immune response modulation and the enigmatic journey of disease progression. Group: Pharmaceutical. Alternative Names: Monosialo (2,6), biantennary (A1); A1 glycan; A2G2S1 N-Glycan; NeuNAc(Gal-GlcNAc)2Man3(GlcNAc)2; Mono-sialylated, galactosylated, bi-antennary N-linked glycan. CAS No. 145211-79-6. Pack Sizes: 1mg;1g;10g. Product ID: 145211-79-6. Molecular formula: C73H121N5O54. Mole weight: 1932.74. Custom synthesis is available. Send your inquiries for more information.
London
A2B N-Glycan
A2B N-Glycan is a fundamental constituent employed in dissecting intricate glycosylation arrangements. It assumes a pivotal function in developing the formulation of therapeutics directed towards a myriad of ailments such as neoplasms, neurodegenerative maladies like Alzheimer's and immune system dysfunctions. Group: Pharmaceutical. Alternative Names: Sialo, bisected, biantennary N-linked glycan. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A2FB N-Glycan
A2FB N-Glycan is an indispensable compound in the biomedical field, playing a significant role in elucidating and deciphering the intricate N-glycosylation profiles discernible in diverse pharmaceuticals and ailments. Group: Pharmaceutical. Alternative Names: sialyl, fucosylated, bisected biantennary N-linked glycan. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A2F Glycan, 2-AA labelled
A2F Glycan, 2-AA labelled, a highly specialized chemical utilized in the biomedical industry, possesses immense potential in decoding the intricate processes of glycosylation in the human body, playing a pivotal role in shedding light on several degenerative diseases, including Alzheimer's and Parkinson's. Its effectiveness lies in serving as an indispensable tool in drug development, with its ability to aid in targeting these illnesses. This scientific marvel has indeed revolutionized the study of glycosylation through its unparalleled contributions to medical research and development. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A2F Glycan, 2-AB labelled
A2F Glycan, 2-AB labelled. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A2F N-Glycan
A2F N-Glycan is a biomolecule widely found in human cells, involved in glycosylation process. It is commonly used in the biomedicine industry for studying age-related macular degeneration (AMD) as well as other diseases related to glycation, such as Alzheimer's and diabetes. A2F N-Glycan also plays a crucial role in developing therapeutic drugs targeted to these diseases. Group: Pharmaceutical. Alternative Names: Disialo, galactosylated, fucosylated, biantennary (A2F); Di-sialylated, galactosylated, core-fucosylated bi-antennary N-linked glycan; FA2G2S2 Glycan; Mannotriose-(fucosyl-di-[N-acetylglucosamine]), bis(sialyl-galactosyl-N-acetylglucosaminyl); (NeuNAc-Gal-GlcNAc)2Man2(Fuc)(GlcNAc)2; A2F glycan; O-(N-Acetyl-α-neuraminosyl)-[2→3(or 2→6)]-O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-O-α-D-mannopyranosyl-(1→3)-O-[O-(N-acetyl-α-neuraminosyl)-[2→3(or 2→6)]-O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→6)]-O-β-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→6)]-2-(acetylamino)-2-deoxy-D-glucose. CAS No. 108341-22-6. Pack Sizes: 1mg;1g;10g. Product ID: 108341-22-6. Molecular formula: C90H148N6O66. Mole weight: 2370.14. Custom synthesis is available. S
London
A2G1 Glycan, 2-AA labelled
A2G1 Glycan, 2-AA labelled is a crucial component in the biomedicine industry used to study glycosylation patterns, which plays a critical role in numerous diseases, including cancer, diabetes, and inflammation. As a fluorescently labelled glycan, it enables researchers to investigate the glycosylation process related to protein-protein and protein-ligand interactions, leading to better understanding and potential therapeutic interventions for these diseases. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A2G1 Glycan, 2-AB labelled
A2G1 Glycan, 2-AB labelled. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A2G1 N-Glycan
A2G1 N-Glycan is a vital component used for studying glycosylation and its impact on diseases such as cancer, autoimmune disorders and neurodegenerative diseases. This glycan plays a crucial role in understanding cellular processes, protein interactions and targeted compound delivery. It aids in the characterization and analysis of glycoproteins. Group: Pharmaceutical. Alternative Names: Asialo-, bi-antennary N-linked glycan. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A2 Glycan, 2-AA labelled
A2 Glycan, 2-AA labelled is a vital tool in biomedicine used for studying glycan structures and their involvement in various diseases. It is utilized to analyze glycan compositions and monitor alterations in glycosylation patterns. Group: Pharmaceutical. Alternative Names: A2 N-linked oligosaccharide; A2G2S2; G2S2. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A2 Glycan, 2-AB labelled
A2 Glycan, 2-AB labelled. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A2 N-Glycan
A2 N-Glycan is an indispensable biocompatible and bioactive glycobiology compound, aiding in the meticulous analysand comprehensive characterization of glycoproteins. Group: Pharmaceutical. Alternative Names: Disialo (2,6), biantennary (A2); A2 glycan; A2G2S2 N-glycan; Di-sialylated, galactosylated, bi-antennary N-linked glycan Mannotriose-di-(N-acetyl-D-glucosamine), bis([N-acetyl-D-neuraminyl]-galactosyl-[N-acetyl-D-glucosaminyl]). CAS No. 71496-55-4. Pack Sizes: 1mg;1g;10g. Product ID: 71496-55-4. Molecular formula: C84H138N6O62. Mole weight: 2224. Custom synthesis is available. Send your inquiries for more information.
London
A3 Glycan, 2-AA labelled
A3 Glycan, 2-AA labelled, a critical and indispensable instrument in the biomedical sector, is utilized for exploring glycan expression in diverse illnesses, notably cancer and autoimmune disorders. It acts as the ideal substance for glycan analysis and characterization by advanced technologies like mass spectrometry and chromatography. Furthermore, A3 Glycan, 2-AA labelled is crucial for triggering glycomics-related biomarker discovery scientific investigations ensuing precision medication breakthroughs. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A3 Glycan, 2-AB labelled
A3 Glycan, 2-AB labelled. Group: Pharmaceutical. Pack Sizes: 1mg;1g;10g. Custom synthesis is available. Send your inquiries for more information.
London
A3 N-Glycan
A3 N-Glycan is a vital biomolecule commonly found on the surface of many cells. It plays a crucial role in various biological processes, such as cell signaling, immune response, and disease progression. This particular N-glycan is extensively studied in the biomedical industry due to its involvement in numerous diseases, including cancer, autoimmune disorders, and infectious diseases. Group: Pharmaceutical. Alternative Names: Trisialylated, galactosylated, triantennary (A3); A3 glycan; A3G3S3 Glycan; (NeuNAc-Gal-GlcNAc)3Man3(GlcNAc)2; Tri-sialylated, galactosylated, tri-antennary N-linked glycan; Mannotriose-di-(N-acetyl-D-glucosamine), tris(sialyl-galactosyl-N-acetyl-D-glucosaminyl; D-Glucose, O-(N-acetyl-α-neuraminosyl)-[2→3(or 2→6)]-O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→2)-O-[O. CAS No. 145164-24-5. Pack Sizes: 1mg;1g;10g. Product ID: 145164-24-5. Molecular formula: C109H178N8O80. Mole weight: 2880.59. Custom synthesis is available. Send your inquiries for more information.
London
6-Azido-6-deoxy-L-galactose
6-Azido-6-deoxy-L-galactose is a highly esteemed compound serving as a formidable molecular probe. It pioneers the examination of glycosylation processes within cellular domains. Distinguished by its distinctive azido group, this remarkable entity unveils an extraordinary capacity for selectively labeling glycan molecules. Such an enigmatic capability graciously assists in comprehending the nuanced contributions of these glycan entities across diverse afflictions, encompassing cancer, viral infections and autoimmune disorders. Group: Pharmaceutical. Alternative Names: 6-azidofucose; (2S,3R,4R,5S)-6-Azido-2,3,4,5-tetrahydroxy-hexanal. CAS No. 70932-63-7. Pack Sizes: 25 mg. Product ID: B1370-001052. Molecular formula: C6H11N3O5. Mole weight: 205.17. Custom synthesis is available. Send your inquiries for more information.
London
Fmoc-Thr[GalNAc(Ac)3-α-D]-OH
Fmoc-Thr[GalNAc(Ac)3-α-D]-OH is a biomedical compound used for the research of diseases involving abnormal glycosylation processes. It functions as a glycosylation inhibitor, targeting enzymes responsible for glycan modification. This product aids in the study and understanding of glycosylation-related disorders. Group: Pharmaceutical. Alternative Names: Fmoc-Thr(Ac3AcNH-α-Gal)-OH; Fmoc-L-Thr(TnAc4)-OH; N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-threonine; Fmoc-Thr[GalNAc(Ac)3-alpha-D]-OH. CAS No. 116783-35-8. Pack Sizes: 25 mg. Product ID: BAT-008014. Molecular formula: C33H38N2O13. Mole weight: 670.66. Custom synthesis is available. Send your inquiries for more information.
London
Methyl N-acetyl-2-deoxy-α-D-galactosamine
Methyl N-acetyl-2-deoxy-α-D-galactosamine is a crucial compound in biomedicine. It is extensively utilized for researching glycosylation and treating diseases related to abnormal glycosylation, such as congenital disorders of glycosylation (CDGs). With its molecular structure and composition, Methyl N-acetyl-2-deoxy-α-D-galactosamine proves valuable in elucidating glycan function and developing potential therapeutic interventions. Group: Pharmaceutical. Alternative Names: methyl 2-acetamido-2-deoxy-alpha-D-galactopyranoside; alphaGalNAcOMe; alpha-D-GalNAc-OMe; Methyl N-acetyl-2-deoxy-alpha-D-galactosamine; N-((2S,3R,4R,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3-yl)acetamide. CAS No. 6082-22-0. Pack Sizes: 1 g. Product ID: B1999-129219. Molecular formula: C9H17NO6. Mole weight: 235.23. Custom synthesis is available. Send your inquiries for more information.
London
UDP-GlcNAz.2Na
UDP-GlcNAz.2Na, a biochemical compound with pivotal importance in the field of glycobiology and metabolic labeling, is a metabolic precursor for the intricate biosynthesis of azide-labeled glycans and glycoconjugates, whilst serving as a critical tool in unraveling the intricacies of glycosylation and glycan-mediated interactions in biological systems. Boasting a manifold of applications, including but not limited to the scrutiny of malignant disorders such as cancer, progressive neurodegenerative diseases as Alzheimer's Disease as well as inflammatory disorders, this molecular compound adds substantive value to multifarious scientific endeavors. Group: Pharmaceutical. Alternative Names: Uridine 5-disphopho-N-acetylazidoglucosamine disodium salt. CAS No. 1611490-64-2. Pack Sizes: 10 mg. Product ID: B2706-383249. Molecular formula: C17H24N6O17P2Na2. Mole weight: 692.05. Custom synthesis is available. Send your inquiries for more information.
London
Uridine 5-diphosphogalactose disodium salt
Uridine 5-diphosphogalactose disodium salt is an indispensable compound in the biomedical field, serving as a fundamental precursor for diverse glycoconjugates and glycans. By actively participating in the formation of cell surface receptors and extracellular matrix molecules, this product assumes a pivotal function in the intricate synthesis of nucleotide sugars and glycosylation processes. Its usability extends to studying drug-resistant epilepsy, neurodegenerative ailments and immunological disorders. Group: Pharmaceutical. Alternative Names: UDP-D-galactose disodium salt; UDP-α-D-Gal disodium salt; Uridine 5'-(trihydrogen diphosphate)? P'-α-D-galactopyranosyl ester disodium salt; UDP-galactose disodium salt. CAS No. 137868-52-1. Pack Sizes: 100 mg. Product ID: B2706-185823. Molecular formula: C15H22N2Na2O17P2. Mole weight: 610.27. Custom synthesis is available. Send your inquiries for more information.
London
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.